Kusajili – Centralise les essais cliniques mondiaux

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control To investigate efficacy, safety and tolerability of BI 1356 versus placebo

• Pays Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine,
• Organes Aucun
• Spécialités Aucun

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions The purpose of this study is - To characterize the pharmacokinetic profile of the Ramipril 10 mg capsules relative to that of ALTACE@ 10 mg capsules in healthy, adult, human, male subjects under non-fasting conditions and to assess the bioequivalence. - To monitor the safety of the subjects.

• Pays India,
• Organes Aucun
• Spécialités Aucun

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Reference Product (B): Prograf (Tacrolimus) Capsules 1 mg, manufactured by Astellas Pharma, Inc., USA in 36 normal, healthy, adult, male subjects under fed condition.

• Pays India,
• Organes Aucun
• Spécialités Aucun